tirzepatide surpass cvot Diabetes Distilled: SURPASS-CVOT – demonstrates cardiovascular benefit in secondary prevention 🫀 EASD 2025: Tirzepatide (SURPASS-CVOT)

Focus on balanced mealsthe goal is fueling at the right level, not continuing to reduce

Consult your healthcare provider to tailor your semaglutide dosage and embark on your journey toward a healthier weight and lifestyle

: 1000 1000

, Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes, N

We provide the full spectrum of care-from initial medical assessment and lab review to prescription management and ongoing virtual follow-ups-all through a secure online platform

Pregnant women exposed to these medications and healthcare providers are encouraged to report exposures: For Semaglutide: Contact Novo Nordisk at 1-877-390-2760 or [www.wegovypregnancyregistry.com]( For Tirzepatide: Contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) Please note that the above list is not complete, and it describes the most common side effects and risks